← Back to Clinical Trials
Recruiting NCT07324109

Clinical Application Observation on the Evaluation of Phantom Limb Pain With the Suralis System

Trial Parameters

Condition Phantom Limb Pain After Amputation
Sponsor Median
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-04-01
Completion 2026-07-31
Interventions
Vibrotactile sensory feedback

Brief Summary

This study tests whether a vibration-based feedback device (Suralis) can reduce phantom limb pain in people with lower-leg amputations over 3 weeks. Participants wear the device daily and report pain levels, walking ability, and quality of life - with no known risks, as it's a CE-certified medical device. If pain improves, the study team will help participants apply for insurance coverage to keep using the system long-term. The goal is to offer a simple, non-drug option that may help ease chronic pain and improve daily function for amputees. Participation is voluntary and can be stopped anytime without affecting medical care.

Eligibility Criteria

Inclusion Criteria: * Unilateral major lower-limb amputation (transtibial or transfemoral) * Presence of persistent phantom limb pain, defined as daily pain intensity ≥ 3/10 on the Visual Analog Scale (VAS) during the baseline period * Regular daily use of a prosthetic limb (minimum 4 hours/day) * Adequate German language proficiency to understand and complete study questionnaires and follow study procedures * Ability to provide informed consent Exclusion Criteria: * Unstable wound or skin condition at the residual limb * Inconsistent prosthetic use (less than daily or \< 4 hours/day) * Poorly fitting or non-functional prosthesis (as determined by study team) * Incapacity to provide informed consent (e.g., due to cognitive impairment or severe psychiatric illness) * Insufficient German language skills to comprehend study materials or complete assessments reliably

Related Trials